Company Updates
Millenium Kapital Ltd (MKL) is pleased to announce the appointment of Robert Nigel Chapman as its Principal Technical Consultant
Millenium Kapital Ltd (MKL) is pleased to announce the appointment of Robert Nigel Chapman as its Principal Technical Consultant. Nigel is the UK qualified Geologist with 29 years experience
Reckoon announces Blockchain based Global WishBasket Shopping Protocol (GloWS)
Reckoon is shaping the future of the retail industry by providing Blockchain & AI Based Global Shopping Platform as a Service
Dovetail Announces Exclusive Site Tour of Projects – Register Now!
Dovetail is beginning 2020 with a clear vision of delivering their 5 townhouse & childcare projects in Melbourne’s Bayside and has coordinated a private site tour for a handful of investors
Simble appointed first app provider in ARENA-funded national smart energy roll-out
Simble’s Energy App to be available for use, via the program, in up to 5,000 homes and small businesses in Australia
Buy. Sell. Buy. Sell. Repeat Until Broke.
For as long as there have been markets, there have been people looking for ways to gain an advantage. From scams and fraud in under-regulated markets before the 1990s to systems and processes in more
Dovetail Signs Experienced Childcare Operating Group After Attracting National Interest
Dovetail’s Aspendale Childcare project has made significant progress, obtaining an executed Head of Agreement with an experienced childcare operating group at the beginning of the year.
Bricklet has listed its first development IBO (Initial Bricklet Offering)
Roxy Muse is a specialist build-to-rent development for the lucrative over-55s market; in Avalon, on Sydney’s Northern Beaches.
This $8M project gives investors access to a wealth opportunity typical
Guarda Systems continues to receive positive media coverage
Our Managing Director (Craig Penty), was extremely pleased to be invited to participate in a podcast with Perth radio station 6PR. The podcast discussed the issue of silicosis in the workplace
Edison research report and publication of Genentech phase I results
We’re pleased to share the latest Edison research report on our lead candidate paxalisib (GDC-0084) joining GBM AGILE, as announced to the ASX in December
Backed By Leading Investment Groups and Family Offices
